Literature DB >> 14974852

Escherichia coli O157:H7 in the gallbladders of experimentally infected calves.

William C Stoffregen1, Joachim F L Pohlenz, Evelyn A Dean-Nystrom.   

Abstract

Fifteen weaned calves (age 89-141 days) were treated with dexamethasone (0.25 mg/kg, IV) for 3 days before, the day of, and the day after inoculation with 10 colony-forming units of either Escherichia coli O157:H7 (strain 86-24, which produces Shiga toxin 2 and intimin; n = 13) or nonpathogenic E. coli (strain 123, which does not produce Shiga toxin or intimin; n = 2). All calves were necropsied 4 days after inoculation. Histologic lesions of attaching and effacing bacteria were observed in the large intestine (12/13) and in the gallbladder mucosa (5/13) of calves inoculated with E. coli 86-24. Cholecystitis was present in 12 of 13 calves that received E. coli 86-24. Inoculum bacteria were recovered from the distal colons or feces (13/13) and gallbladders (3/4) of calves inoculated with 86-24.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14974852     DOI: 10.1177/104063870401600114

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  12 in total

1.  Distribution of Shiga-toxigenic Escherichia coli O157 in the gastrointestinal tract of naturally O157-shedding cattle at necropsy.

Authors:  James E Keen; William W Laegreid; Carol G Chitko-McKown; Lisa M Durso; James L Bono
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

2.  Host immune status influences the development of attaching and effacing lesions in weaned pigs.

Authors:  Francis Girard; Isabelle P Oswald; Ionélia Taranu; Pierre Hélie; Greg D Appleyard; Josée Harel; John M Fairbrother
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.

Authors:  Mark A Hoffman; Christian Menge; Thomas A Casey; William Laegreid; Brad T Bosworth; Evelyn A Dean-Nystrom
Journal:  Clin Vaccine Immunol       Date:  2006-10-18

4.  Prevalence of Escherichia coli O157:H7 in gallbladders of beef cattle.

Authors:  S Reinstein; J T Fox; X Shi; T G Nagaraja
Journal:  Appl Environ Microbiol       Date:  2006-12-08       Impact factor: 4.792

5.  Responses of cattle to gastrointestinal colonization by Escherichia coli O157:H7.

Authors:  Pablo Nart; Stuart W Naylor; John F Huntley; Iain J McKendrick; David L Gally; J Christopher Low
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

6.  Epithelial and mesenchymal cells in the bovine colonic mucosa differ in their responsiveness to Escherichia coli Shiga toxin 1.

Authors:  Ivonne Stamm; Melanie Mohr; Philip S Bridger; Elmar Schröpfer; Matthias König; William C Stoffregen; Evelyn A Dean-Nystrom; Georg Baljer; Christian Menge
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

7.  Escherichia coli O157:H7 strains that persist in feedlot cattle are genetically related and demonstrate an enhanced ability to adhere to intestinal epithelial cells.

Authors:  Brandon A Carlson; Kendra K Nightingale; Gary L Mason; John R Ruby; W Travis Choat; Guy H Loneragan; Gary C Smith; John N Sofos; Keith E Belk
Journal:  Appl Environ Microbiol       Date:  2009-07-17       Impact factor: 4.792

8.  Impact of dexamethasone-induced immunosuppression on the duration and level of shedding of Escherichia coli O157:H7 in calves.

Authors:  Sruti Sreerama; Michael W Sanderson; Melinda Wilkerson; T G Nagaraja
Journal:  Curr Microbiol       Date:  2008-03-11       Impact factor: 2.188

9.  Early attachment sites for Shiga-toxigenic Escherichia coli O157:H7 in experimentally inoculated weaned calves.

Authors:  Evelyn A Dean-Nystrom; William C Stoffregen; Brad T Bosworth; Harley W Moon; Joachim F Pohlenz
Journal:  Appl Environ Microbiol       Date:  2008-08-22       Impact factor: 4.792

10.  Changes in bacterial community composition of Escherichia coli O157:H7 super-shedder cattle occur in the lower intestine.

Authors:  Rahat Zaheer; Eric Dugat-Bony; Devon Holman; Elodie Cousteix; Yong Xu; Krysty Munns; Lorna J Selinger; Rutn Barbieri; Trevor Alexander; Tim A McAllister; L Brent Selinger
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.